REFERENCES
  1. De Sanctis V, Kattamis C, Canatan D, Soliman AT, Elsedfy H, Karimi M, Daar S, Wali Y, Yassin M, Soliman N, Sobti P. β-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterranean journal of hematology and infectious diseases. 2017;9(1).
  2. Abdulla MA, Yassin MA, Abdelrazek M, Mudawi D, Ibrahim F, Soliman DS, ElOmri H, Nashwan AJ, Fernihough L, De Sanctis V, Soliman AT. A persistent cough as atypical clinical presentation of intrathoracic extramedullary hematopoiesis (EMH) in a female with thalassemia intermedia. Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl 2):41.
  3. Garg K, Singh PK, Singh M, Chandra PS, Sharma BS. Long segment spinal epidural extramedullary hematopoiesis. Surg Neurol Int . 2013; 4:161. Published 2013 Dec 26. doi:10.4103/2152-7806.123657
  4. Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6):1383-1391. doi:10.1016/j.pcl.2013.08.008
  5. Nashwan AJ, Yassin MA, Babu GD, Nair SL, Libo-on IL, Hijazi HA, De Sanctis V, Soliman A. Quality of life among adolescents aged 14 to 18 years with beta-thalassemia major (TM) in Qatar. Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl 2):16.
  6. Tassiopoulos T, Rombos Y, Konstantopoulos K, Revenas K, Tassiopoulos S, Aessopos A. Spleen size in beta-thalassaemia heterozygotes. Haematologia (Budap). 1995;26(4):205-209.
  7. Kanbour I, Chandra P, Soliman A, De Sanctis V, Nashwan A, Abusamaan S, Moustafa A, Yassin MA. Severe liver iron concentrations (LIC) in 24 patients with β-thalassemia major: correlations with serum ferritin, liver enzymes and endocrine complications. Mediterranean journal of hematology and infectious diseases. 2018;10(1).
  8. Yassin MA, Soliman AT, De Sanctis V, Abdelrahman MO, Bedair EM, AbdelGawad M. Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis. Indian journal of endocrinology and metabolism. 2014 Jul;18(4):546.
  9. Soliman AT, Al Yafei F, Al-Naimi L, Almarri N, Sabt A, Yassin M, De Sanctis V. Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years. Indian journal of endocrinology and metabolism. 2013 Nov;17(6):1090.
  10. De Sanctis V, Soliman AT, Elsedfy H, Pepe A, Kattamis C, El Kholy M, Yassin M. Diabetes and glucose metabolism in thalassemia major: an update. Expert review of hematology. 2016 Apr 2;9(4):401-8.
  11. De Sanctis V, Soliman AT, Candini G, Yassin M, Raiola G, Galati MC, Elalaily R, Elsedfy H, Skordis N, Garofalo P, Anastasi S. Insulin-like growth factor-1 (IGF-1): demographic, clinical and laboratory data in 120 consecutive adult patients with thalassaemia major. Mediterranean journal of hematology and infectious diseases. 2014;6(1).
  12. De Sanctis V, Elsedfy H, Soliman AT, Elhakim IZ, Pepe A, Kattamis C, Soliman NA, Elalaily R, El Kholy M, Yassin M. Acquired hypogonadotropic hypogonadism (AHH) in thalassaemia major patients: an underdiagnosed condition?. Mediterranean journal of hematology and infectious diseases. 2016;8(1).
  13. Coşkun E, Keskin A, Süzer T, Sermez Y, Kildaci T, Tahta K. Spinal cord compression secondary to extramedullary hematopoiesis in thalassemia intermedia. Eur Spine J. 1998;7(6):501-504. doi:10.1007/s005860050114